. . . . . . . . . . . . . "p(RGD:Ngf) -> p(RGD:Casp2)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "Caspase-2 in its pro-form was processed to its intermediate forms and to final active product p14 when treated with NGF. Caspase-2 was preferentially activated 3.5-fold during NGF-induced oligodendrocyte apoptosis." . . "Selventa" . . . . "2014-07-03T14:29:46.447+02:00"^^ . . .